Skip to content

Contour 3D® 690R36Recalls & reported problems

Medtronic, Inc. · RING 690R36 CONTOUR 3D 26L MEX · Class 2 · Implant

All models of Contour 3D (12)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
10
Deaths reported
0
Injuries reported
10
Recalls naming it
0

Summary

The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 00643169121720), received between Aug 7, 2017 and Oct 23, 2024 — classified as 10 injuries.

The most frequently reported specific device problem is “Inadequacy of Device Shape and/or Size” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 2 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Inadequacy of Device Shape and/or Size3
  • Insufficient Device Problem Information3
  • Appropriate Device Problem Term/Code Not Available1
  • Intravalvular regurgitation1
  • Patient Device Interaction Problem1
  • Perivalvular Leak1

Patient problems

  • No Information4
  • Hematoma2
  • Atrial Fibrillation1
  • Bradycardia1
  • Convulsion/Seizure1
  • Hemothorax1
  • Insufficient Information1
  • Mitral Regurgitation1

Recent adverse event reports

The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 23, 2024Intravalvular regurgitation; Intravalvular regurgitation

    MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR AND 3 MONTHS POST IMPLANT OF THIS 36MM ANNULOPLASTY RING, SEVERE MITRAL REGURGITATION WAS OBSERVED ON A TRANSTHORACIC ECHOCARDIOGRAM (TTE). ANOTHER TTE APPOINTMENT IS SCHEDULED IN 6 MONTHS FOR A CHECK-UP. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 20513128 ↗
  • InjurySep 23, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT 6 DAYS POST IMPLANT OF THIS 36MM TRICUSPID ANNULOPLASTY RING, IT WAS REPORTED THAT THE PATIENT HAD A LEFT HEMOTHORAX. IT WAS FURTHER NOTED THAT A LARGE HEMATOMA AT THE APEX OF THE HEMITHORAX WAS DISCOVERED ALONG WITH A FAIR AMOUNT OF SANGUINEOUS FLUID. ASPIRATION WAS PERFORMED TO EVACUATE THE CLOT AND FLUID. 500CC OF ANTIBIOTIC WATER WAS INSTILLED. APPROXIMATELY 1 LITER OF CLOT AND BLOOD WAS EVACUATED. NO EVIDENCE OF ACTIVE BLEEDING WAS NOTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Hematoma; Hemothorax

    MAUDE report 20285808 ↗
  • InjuryMar 11, 2024Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available

    MEDTRONIC RECEIVED INFORMATION THAT 1 WEEK POST IMPLANT OF THIS 36MM TRICUSPID ANNULOPLASTY RING, IT WAS REPORTED THAT A COMPUTERIZED TOMOGRAPHY (CT) DIAGNOSTIC DISCOVERED THE PATIENT HAD AN EPILEPTIC SEIZURE. MEDICATION WAS ADMINISTERED. IT WAS ALSO REPORTED THAT THE PATIENT WAS ALREADY VERY AGITATED DURING THE NIGHT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Convulsion/Seizure

    MAUDE report 18882072 ↗
  • InjuryMar 1, 2024Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT ON THE SAME DAY POST IMPLANT OF THIS 38MM MITRAL ANNULOPLASTY RING AND 36MM TRICUSPID ANNULOPLASTY RING, HEMATOPERICARDIUM WAS REPORTED. IT WAS STATED THAT THE LEFT RETROCARDIAC SPACE WAS OBSERVED TO BE COMPLETELY COMPRESSED ON A CHEST X-RAY. A RE-THORACOTOMY WITH HEMATOMA REMOVAL AND HEMOSTASIS WAS PERFORMED ON THE FOLLOWING DAY. AFTER RETHORACOTOMY, A BLEEDING IN THE AREA OF THE LEFT ATRIAL INCISION WAS NOTED. A BLOOD TRANSFUSION WAS ALSO PERFORMED. THE SITE ASSESSED THE EVENT AS NOT RELATED TO THE DEVICES. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Hematoma; Pericardial Effusion

    MAUDE report 18816542 ↗
  • InjuryJan 25, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT 6 DAYS FOLLOWING THE IMPLANT OF THIS TRICUSPID ANNULOPLASTY BAND, THE PATIENT DEVELOPED BRADYCARDIA WITH HEART RATE REPORTED AS 26 BEATS PER MINUTE (BPM). IT WAS REPORTED THAT 1 DAY LATER, A PERMANENT PACEMAKER WAS IMPLANTED. IT WAS ALSO REPORTED THAT THE DISCHARGE ELECTROCARDIOGRAM (ECG) PERFORMED NOTED WIDENED QRS COMPLEXES AND LEFT BUNDLE BRANCH BLOCK (LBBB). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation; Bradycardia; Non specific EKG/ECG Changes

    MAUDE report 13353097 ↗
  • InjuryFeb 12, 2021Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 36MM TRICUSPID ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A NON MEDTRONIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 11323914 ↗
  • InjuryApr 19, 2019Inadequacy of Device Shape and/or Size; Inadequacy of Device Shape and/or Size

    MEDTRONIC RECEIVED INFORMATION THAT THIS 36MM TRICUSPID ANNULOPLASTY RING WAS IMPLANTED AND EXPLANTED DURING THE SAME PROCEDURE. THE DEVICE WAS REPLACED WITH A 30MM TRICUSPID ANNULOPLASTY RING OF THE SAME MODEL FOR UNKNOWN REASONS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Information

    MAUDE report 8531116 ↗
  • InjuryDec 6, 2018Inadequacy of Device Shape and/or Size; Inadequacy of Device Shape and/or Size

    MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY AFTER THE IMPLANT OF THIS 36MM ANNULOPLASTY RING, THE RING WAS EXPLANTED AND REPLACED WITH A 32MM ANNULOPLASTY RING AS THE FIT WAS INADEQUATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Information

    MAUDE report 8137986 ↗
  • InjuryMar 2, 2018Perivalvular Leak; Inadequacy of Device Shape and/or Size; Insufficient Device Problem Information; Perivalvular Leak; Inadequacy of Device Shape and/or Size; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT BOTH A 36 MM TRICUSPID ANNULOPLASTY RING AND A 32 MM TRICUSPID ANNULOPLASTY RING WERE IMPLANTED AND EXPLANTED DURING THE SAME PROCEDURE FOR UNKNOWN REASONS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Information

    MAUDE report 7309905 ↗
  • InjuryAug 7, 2017Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT THIS ANNULOPLASTY RING WAS IMPLANTED AND EXPLANTED ON THE SAME DAY FOR UNKNOWN REASONS. NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Mitral Regurgitation; No Information

    MAUDE report 6772482 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page